Core Insights - Henry Schein, Inc. reported strong fourth quarter sales growth, achieving the highest sales growth in 15 quarters, driven by global equipment, specialty products, and technology businesses [10][11] - The company is on track to exceed its goal of having over 50% of non-GAAP operating income from high-growth, high-margin businesses by the end of its strategic planning cycle in 2027 [11] - The implementation of the BOLD+1 strategic plan is progressing well, with significant advancements in e-commerce and innovative solutions for customer care [12][13] Financial Performance - Global sales for the fourth quarter reached $3.4 billion, reflecting a 7.7% growth compared to 2024, with constant currency sales growth of 5.8% [32] - Non-GAAP net income for the fourth quarter was $160 million, or $1.34 per diluted share, compared to $149 million, or $1.19 per diluted share in the prior year [34] - The effective tax rate for 2025 on a non-GAAP basis was 22.7%, slightly higher than the previous year's rate of 22% [33] Business Segments - The Global Distribution and Value Added Services Group saw sales growth of 7%, with U.S. dental merchandise sales growing by 3.6% and U.S. dental equipment sales increasing by 10.6% [35] - The Global Specialty Products Group experienced a sales increase of 14.6%, driven by strong performance in implants and biomaterials [38] - The Global Technologies Group reported total sales growth of 8.4%, with significant contributions from practice management software [38] Strategic Initiatives - The company is focusing on value creation initiatives expected to deliver over $200 million in operating income improvement over the next few years [39] - A new partnership with Amazon Web Services aims to integrate generative AI technology into Henry Schein's products, enhancing customer service and operational efficiency [29][30] - The rollout of the global e-commerce platform, henryschein.com, is expected to be completed for U.S. dental and Canadian customers in the first quarter of the year [12] Market Outlook - The U.S. dental market is showing signs of stability and positive growth, with patient traffic remaining stable and a favorable outlook for equipment investments [16][55] - International dental merchandise sales grew by 9.2%, benefiting from a weaker U.S. dollar and strong performance across various markets [23] - The company anticipates 2026 sales growth of 3% to 5% over 2025, with non-GAAP diluted EPS expected to be in the range of $5.23 to $5.37 [41]

Financial Data and Key Metrics Changes - Global sales for Q4 2025 reached $3.4 billion, reflecting a sales growth of 7.7% compared to Q4 2024, with constant currency sales growth of 5.8% and a 1.9% increase from foreign currency exchange [29][30] - GAAP operating margin for Q4 2025 was 4.76%, a decrease of 10 basis points from the prior year, while non-GAAP operating margin was 7.42%, relatively flat compared to the previous year [30] - Q4 2025 GAAP net income was $101 million or $0.85 per diluted share, compared to $94 million or $0.74 per diluted share in the prior year [30][31] Business Line Data and Key Metrics Changes - Global distribution and value-added services group sales grew by 7.0%, with U.S. dental merchandise sales increasing by 3.6% and U.S. dental equipment sales growing by 10.6% [32] - Global specialty products group sales grew by 14.6%, driven by strong performance in implants and biomaterials, with double-digit growth in value implants [33][24] - Global technology group sales increased by 8.4%, with significant growth in practice management software, particularly Dentrix Ascend [33][26] Market Data and Key Metrics Changes - International dental merchandise sales grew by 9.2%, with strong performance across Southern and Eastern Europe, Germany, Brazil, and Canada [32] - U.S. medical distribution sales grew by 4.9%, reflecting strong demand in home solutions, although respiratory product demand decreased [21][22] - International dental equipment sales grew by 13.9%, with broad-based growth across many countries and equipment categories [32][23] Company Strategy and Development Direction - The company is executing its 2025-2027 BOLD+1 strategic plan, with non-GAAP operating income from high-growth, high-margin businesses approaching 50% of total operating income [12] - The rollout of the global e-commerce platform, henryschein.com, is underway, with expectations to complete the rollout to U.S. Dental and Canadian customers in Q1 2026 [13] - The company is focusing on innovative solutions to enhance patient care and operational efficiency, including partnerships with Amazon Web Services for AI integration [14][27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the stability and positive trends in the U.S. dental market, with indications of increased patient traffic and investment in technology by dentists [52][54] - The company anticipates earnings growth to be more heavily weighted towards the second half of 2026 due to ongoing value creation initiatives [58] - Management noted that the market is stable, with positive sentiment among dentists regarding investments in new technologies [52][54] Other Important Information - The company repurchased approximately 2.8 million shares of common stock at an average price of $71.10 per share, totaling $200 million [36] - The effective tax rate for Q4 2025 on a non-GAAP basis was 22.7%, compared to 22% for Q4 2024 [30] - The company expects 2026 sales growth to be in the range of 3%-5% over 2025, with non-GAAP diluted EPS projected to be between $5.23 and $5.37 [38] Q&A Session Summary Question: Guidance on operating income improvement plan - Management indicated that the benefits from value creation initiatives will be more heavily weighted to the back half of the year, with some lumpiness expected in the first half [44][58] Question: Growth in specialty value implants - Management noted strong growth in specialty value implants and indicated stable pricing within the market, with no unusual price increases [47][49] Question: Durability of dental market performance - Management confirmed that the dental market is stable and leaning positively, with good feelings among dentists about investing in technology [52][54] Question: Sustainability of implant performance - Management expressed optimism about the implant market, particularly in Europe, while noting that U.S. growth is more stable but not as robust [70][72]

Financial Data and Key Metrics Changes - Global sales for Q4 2025 reached $3.4 billion, reflecting a sales growth of 7.7% compared to Q4 2024, with constant currency sales growth of 5.8% and a 1.9% increase from foreign currency exchange [29] - GAAP operating margin for Q4 2025 was 4.76%, a decrease of 10 basis points from the prior year, while non-GAAP operating margin was 7.42%, relatively flat compared to the prior year [30] - Q4 2025 GAAP net income was $101 million or $0.85 per diluted share, compared to $94 million or $0.74 per diluted share in the prior year [30] - Non-GAAP net income for Q4 2025 was $160 million or $1.34 per diluted share, compared to $149 million or $1.19 per diluted share in the prior year [31] Business Line Data and Key Metrics Changes - Global distribution and value-added services group sales grew by 7.0%, with U.S. dental merchandise sales increasing by 3.6% and U.S. dental equipment sales growing by 10.6% [32] - Global specialty products group sales grew by 14.6%, driven by strong performance in implants and biomaterials [33] - Global technology group sales grew by 8.4%, with significant contributions from practice management software [33] Market Data and Key Metrics Changes - U.S. dental merchandise sales growth reflected continued market share gains, with January 2026 sales showing good momentum [18] - International dental merchandise sales grew by 9.2% in constant currencies, with strong growth across Southern and Eastern Europe, Germany, Brazil, and Canada [32] - U.S. medical distribution sales grew by 4.9%, reflecting strong growth in home solutions, while international dental equipment sales grew by 13.9% [32][33] Company Strategy and Development Direction - The company is executing its 2025-2027 BOLD+1 strategic plan, with non-GAAP operating income from high-growth, high-margin businesses approaching 50% of total operating income [12][13] - The rollout of the global e-commerce platform, henryschein.com, is underway, with expectations to complete the rollout to U.S. Dental and Canadian customers in Q1 2026 [14] - The company is focusing on innovative solutions to enhance patient care and operational efficiency, including partnerships with Amazon Web Services for AI integration [14][27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the stability of the U.S. dental market, with positive trends in patient traffic and dentist investments in technology [51][54] - The company anticipates earnings growth to be more heavily weighted towards the second half of 2026 due to ongoing value creation initiatives [58] - Management noted that the international dental equipment market is performing well, with broad-based growth across many countries [23][32] Other Important Information - The company repurchased approximately 2.8 million shares of common stock at an average price of $71.10 per share, totaling $200 million [35] - Operating cash flow for Q4 2025 was $381 million, compared to $204 million in Q4 2024, driven by working capital management [36] Q&A Session Summary Question: Guidance on operating income improvement plan - Management indicated that the benefits from value creation initiatives will be more heavily weighted to the back half of the year, with some lumpiness expected in the first half [43][44] Question: Growth in specialty value implants - Management noted strong growth in specialty value implants and indicated stable pricing within the market, with no unusual price increases [46][48] Question: Durability of dental market performance - Management confirmed that the U.S. dental market is stable and leaning positively, with good feelings among dentists regarding investments in technology [50][54] Question: Sustainability of implant performance - Management expressed optimism about the implant market, particularly in Europe, while noting that U.S. growth is currently less than 5% [72][73]

Core Insights - Henry Schein, Inc. (HSIC) reported third-quarter 2025 adjusted earnings per share (EPS) of $1.38, reflecting a 13.1% increase year over year and surpassing the Zacks Consensus Estimate by 8.7% [1][8] - The company achieved net sales of $3.34 billion, a 5.4% year-over-year increase, also exceeding the Zacks Consensus Estimate by 2% [2][8] - HSIC raised its full-year 2025 adjusted EPS forecast to a range of $4.88 to $4.96, up from the previous range of $4.80 to $4.94, indicating confidence in future performance [12][14] Financial Performance - Adjusted operating profit for the quarter was $266 million, down 1.1% year over year, with an adjusted operating margin of 8%, contracting by 51 basis points [9] - Gross profit totaled $1.03 billion, a 3.3% increase year over year, but gross margin contracted by 56 basis points to 30.7% due to a 6% rise in the cost of sales [7][9] Revenue Breakdown - Global Distribution and Value-Added Services segment sales rose 4.8% year over year to $2.84 billion, exceeding the forecast of $2.77 billion [3] - Global Dental Distribution merchandise sales increased by 2.9% in constant currencies, while equipment sales grew by 3.4% [4] - Global Medical Distribution sales jumped 4.6% in constant currencies, driven by strong growth in medical products and pharmaceuticals [4] Segment Performance - Global Specialty Products segment sales reached $369 million, up 5.9% on a reported basis, reflecting strong growth in dental implants and endodontics [5] - Global Technology segment sales totaled $173 million, a 9.7% increase on a reported basis, driven by cloud-based software adoption and new revenue cycle management solutions [6] Strategic Initiatives - The company successfully executed its BOLD+1 strategic plan, focusing on operational efficiency, enhancing customer experience, and expanding its digital solutions [14] - Henry Schein announced value creation initiatives expected to deliver over $200 million in operating income improvement over the next few years [13] Liquidity and Share Repurchase - At the end of Q3 2025, Henry Schein had cash and cash equivalents of $136 million, down from $145 million at the end of Q2 [10] - The company repurchased approximately 3.3 million shares at an average price of $68.62 per share, totaling around $229 million, with $980 million authorized for future repurchases [11]